Two-Year Changes in Hyperuricemia and Risk of Diabetes: A Five-Year Prospective Cohort Study
Table 1
Distribution of potential confounding factors of participants grouped by change of hyperuricemia from 2009 to 2011.
Baseline characteristic
Changes of hyperuricemia
No hyperuricemia
Remittent hyperuricemia
Incident hyperuricemia
Persistent hyperuricemia
Male (, %)
5998 (50.42)
1022 (79.47)
683 (78.06)
1148 (85.29)
Age (years)
42.31 ± 13.59
45.01 ± 14.79
42.96 ± 15.07
46.88 ± 15.30
BMI (kg/m2)
23.81 ± 3.34
26.06 ± 3.33
25.91 ± 3.31
26.8 ± 3.05
SBP (mm Hg)
114.86 ± 14.80
121.44 ± 14.15
121.73 ± 15.12
123.21 ± 14.31
DBP (mm Hg)
75.34 ± 9.08
79.51 ± 9.16
79.78 ± 9.92
80.73 ± 9.32
TC (mmol/L)
4.83 ± 0.91
5.11 ± 0.99
4.96 ± 0.90
5.22 ± 0.98
TG (mmol/L)
1.27 ± 0.99
1.99 ± 1.65
1.77 ± 1.23
2.28 ± 1.84
HDLC (mmol/L)
1.38 ± 0.32
1.23 ± 0.29
1.23 ± 0.27
1.18 ± 0.25
High school or higher education (, %)
11732 (98.62)
1274 (99.07)
864 (98.74)
1330 (98.81)
Physical activity (, %)
Low
1023 (8.60)
73 (5.68)
54 (6.17)
74 (5.50)
Moderate
10513 (88.37)
1180 (91.76)
802 (91.66)
1240 (92.12)
High
360 (3.03)
33 (2.57)
19 (2.17)
32 (2.38)
Smoking status (, %)
600 (5.04)
85 (6.61)
62 (7.09)
121 (8.99)
Drinking status (, %)
1034 (8.69)
137 (10.65)
85 (9.71)
191 (14.19)
Family history of diabetes (%)
698 (5.87)
58 (4.51)
53 (6.06)
103 (7.65)
. Data were presented as the mean ± standard deviation or number (%). BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure; TC = total cholesterol; TG = triglycerides; HDLC = high-density lipoprotein cholesterol.
